United Therapeutics Chairperson, CEO Martine A. Rothblatt reports disposal of $4.4 million in shares
UTHR•Martine A. Rothblatt reported exercising options for 9,500 United Therapeutics shares at $117.76, while a family trust sold 9,500 shares at weighted-average prices ranging from $488.6962 to $500.05 on Sept. 23.
1. Share transactions
The family trust’s common-stock holdings fell to 324,443 shares after the sales, while its stock-option holdings rose to 375,910 following the exercise.
